Efficacy of Medical Therapies for Fistulizing Crohn’s Disease: Systematic Review and Meta-analysis Matthew J. Lee, Claire E. Parker, Sarah R. Taylor, Leonardo Guizzetti, Brian G. Feagan, Alan J. Lobo, Vipul Jairath Clinical Gastroenterology and Hepatology Volume 16, Issue 12, Pages 1879-1892 (December 2018) DOI: 10.1016/j.cgh.2018.01.030 Copyright © 2018 AGA Institute Terms and Conditions
Figure 1 Drug therapy vs placebo for induction of fistula response. CI, confidence interval; M-H, Mantel Haenszel. Clinical Gastroenterology and Hepatology 2018 16, 1879-1892DOI: (10.1016/j.cgh.2018.01.030) Copyright © 2018 AGA Institute Terms and Conditions
Figure 2 Drug therapy vs placebo for induction of fistula remission. CI, confidence interval; M-H, Mantel Haenszel. Clinical Gastroenterology and Hepatology 2018 16, 1879-1892DOI: (10.1016/j.cgh.2018.01.030) Copyright © 2018 AGA Institute Terms and Conditions
Figure 3 Drug therapy vs placebo for maintenance of fistula response. CI, confidence interval; M-H, Mantel Haenszel. Clinical Gastroenterology and Hepatology 2018 16, 1879-1892DOI: (10.1016/j.cgh.2018.01.030) Copyright © 2018 AGA Institute Terms and Conditions
Figure 4 Drug therapy vs placebo for maintenance of fistula remission. CI, confidence interval; M-H, Mantel Haenszel. Clinical Gastroenterology and Hepatology 2018 16, 1879-1892DOI: (10.1016/j.cgh.2018.01.030) Copyright © 2018 AGA Institute Terms and Conditions